Pasithea Therapeutics Cor...
(KTTA)
undefined
undefined%
At close: undefined
3.10
-1.90%
After-hours Jan 03, 2025, 05:08 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -15.51M | -13.94M | -2.17M | -40.98K |
| Depreciation & Amortization | 648.45K | 32.37K | 1.38K | n/a |
| Stock-Based Compensation | 592.27K | 835.06K | 471.25K | n/a |
| Other Working Capital | 1.57M | -831.78M | -329.44K | 2.29K |
| Other Non-Cash Items | -732.57K | -1.07M | 750.00K | 9.90K |
| Deferred Income Tax | n/a | n/a | -2.33M | n/a |
| Change in Working Capital | 1.57M | -138.44K | 111.23K | 2.29K |
| Operating Cash Flow | -13.43M | -14.56M | -3.17M | -38.69K |
| Capital Expenditures | -34.30K | -2.14M | -21.50K | n/a |
| Acquisitions | n/a | 77.06K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 433.31K | -626.90K | n/a | n/a |
| Investing Cash Flow | 399.01K | -2.06M | -21.50K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -3.73M | -3.21M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | -3.21K | 5.69M | 282.34K |
| Financial Cash Flow | -3.73M | -3.21M | 55.93M | 282.34K |
| Net Cash Flow | -16.76M | -19.82M | 52.72M | 243.65K |
| Free Cash Flow | -12.85M | -16.70M | -3.20M | -38.69K |